Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Unresectable Renal Cell Carcinoma
NCT00459979Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Mar 2007
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Case Comprehensive Cancer Center. Started Mar 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00459979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00459979.